Compare TNC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNC | RLAY |
|---|---|---|
| Founded | 1870 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 1994 | 2020 |
| Metric | TNC | RLAY |
|---|---|---|
| Price | $61.70 | $10.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $91.00 | $14.50 |
| AVG Volume (30 Days) | 225.0K | ★ 1.9M |
| Earning Date | 05-27-2026 | 05-27-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ 2.36 | N/A |
| Revenue | ★ $1,137,600,000.00 | $15,355,000.00 |
| Revenue This Year | $5.44 | N/A |
| Revenue Next Year | $5.28 | $178.50 |
| P/E Ratio | $26.11 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $60.18 | $1.78 |
| 52 Week High | $85.91 | $11.43 |
| Indicator | TNC | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 24.55 | 62.86 |
| Support Level | $60.18 | $2.99 |
| Resistance Level | $83.87 | $11.43 |
| Average True Range (ATR) | 2.51 | 0.67 |
| MACD | -1.24 | 0.05 |
| Stochastic Oscillator | 6.12 | 56.41 |
Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).